Publication | Closed Access
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MS
70
Citations
17
References
2011
Year
Systemic TreatmentImmunologyClinical TrialsPharmacotherapyAdditional Efficacy EndpointsImmunotherapyMedicineNovel Therapy
| Year | Citations | |
|---|---|---|
Page 1
Page 1